CSL Behring - Company & Market Research Reports

Home /
Companies /
CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

REFINE BY

KEYWORD

Rare Hemophilia Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
83 Pages
Global

From

€3500EUR$4,228USD£3,156GBP

Von Willebrand Disease Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
111 Pages
Global

From

€4212EUR$4,750USD£3,670GBP

RNA Therapeutics Market and RNA Vaccines Market Industry Trends and Global Forecasts to 2035, by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key Geographical Regions and Leading Players

 Report
March 2025
170 Pages
Global

From

€4256EUR$4,799USD£3,708GBP

Kidney Transplant Market - Global Strategic Business Report

 Report
April 2026
381 Pages
Global

From

€5188EUR$5,850USD£4,520GBP

Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-Users and Key Geographical Regions

 Report
December 2025
343 Pages
Global

From

€4256EUR$4,799USD£3,708GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Fibrin Sealants - Global Strategic Business Report

 Report
April 2026
372 Pages
Global

From

€5188EUR$5,850USD£4,520GBP

Hemophilia Drugs - Global Strategic Business Report

 Report
April 2026
182 Pages
Global

From

€5188EUR$5,850USD£4,520GBP

Bleeding Disorder Drugs Market - Global Strategic Business Report

 Report
April 2026
488 Pages
Global

From

€5188EUR$5,850USD£4,520GBP

Immune Thrombocytopenia Drugs - Global Strategic Business Report

 Report
April 2026
384 Pages
Global

From

€5188EUR$5,850USD£4,520GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026

 Report
March 2026
600 Pages
Global

From

€3543EUR$3,995USD£3,086GBP

Intravenous Immunoglobulin (IVIG) Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

 Report
November 2024
94 Pages
Global

From

€3500EUR$4,228USD£3,156GBP

Distribution Deals in Pharmaceuticals and Biotechnology 2020-2026

 Report
March 2026
300 Pages
Global

From

€3543EUR$3,995USD£3,086GBP

Asia-Pacific Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

 Report
December 2022
181 Pages
Asia Pacific

From

€3059EUR$3,450USD£2,665GBP

Middle East and Africa Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

 Report
December 2022
171 Pages
Middle East, Africa

From

€3059EUR$3,450USD£2,665GBP

Europe Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

 Report
December 2022
186 Pages
Europe

From

€3059EUR$3,450USD£2,665GBP

Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

 Report
December 2024
438 Pages
Global

From

€3547EUR$4,000USD£3,090GBP

Rare Hemophilia Factors Market Size, Share & Trends Analysis Report by Factor Deficiency Type, Drug Class (Recombinant Therapies, Prophylactic Treatments), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region with Growth Forecasts, 2025-2030

 Report
February 2025
100 Pages
Global

From

€5276EUR$5,950USD£4,597GBP

Myasthenia Gravis Treatment - Global Strategic Business Report

 Report
April 2026
271 Pages
Global

From

€5188EUR$5,850USD£4,520GBP

Immune Thrombocytopenia Drug Market (2024 Edition): Analysis By Treatment (Intravenous Immunoglobulins, Thrombopoietin Receptor Agonists, Corticosteroids, Others), By Type, By End-User, By Region: Market Insights and Forecast (2019-2029)

 Report
March 2024
254 Pages
Global

From

€2173EUR$2,450USD£1,893GBP

Adeno-Associated Viral (AAV) Vector Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapy, Therapeutic Area, Route of Administration, Scale of Operation and Geographical Regions

 Report
August 2025
470 Pages
Global

From

€4256EUR$4,799USD£3,708GBP

275 Results (Page 2 of 14)
- 1
- 2
- 3
- 4

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.